Nova Scotia Pharmacare

Manufacturer Price Change Requests

Centralized Price Change Process for Generic Drugs

The pan-Canadian Pharmaceutical Alliance (pCPA) has introduced a centralized price change process and submissions can now be made directly to the pCPA for generic molecules This new process allows manufacturers to only make one submission by sending the completed request form to the pCPA instead of each individual drug plan. This new process will be more efficient. 

The deadline for price increase requests for April 1^st implementation will be December 31, 2024.  

If you have questions, please reach out to the pCPA’s generics team. 

Price Change Process for Brand Drugs

Manufacturers can submit requests for price changes by completing the request form and submit to ns.pharmacare.price.list@medavie.bluecross.ca and pharm.pricing@novascotia.ca. Nova Scotia will use CPI as a reference for price increase requests. 

The deadline for price increase requests for April 1^st implementation will be December 31, 2024.  

Note: Incomplete or late submissions will not be eligible for review.

A price decreases for any drug can be implemented at any time, with sufficient notice for publication.

Manufacturers are responsible for implementing price changes through wholesale/distribution networks. Nova Scotia reimburses at list price and not wholesale price.